Peter Chapman Cook serves as Executive at Biota Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Peter Chapman Cook has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 1, 2013 involved receiving (via award) 8,700 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 1, 2013 | BOTA | $0 | Award | 8,700 | $N/A | Discretionary |
Peter Chapman Cook currently holds 100,127 shares of Biota Pharmaceuticals, Inc. (BOTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Chapman Cook has been a net neutral trader of BOTA stock. They have purchased $0 and sold $0 worth of shares.
Peter Chapman Cook's most recent insider trade was on May 1, 2013, when they sold 8,700 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted